Cargando…
Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
Arsenic trioxide (ATO) is one of the first-line chemotherapeutic drugs for acute promyelocytic leukemia. Its anti-cancer activities against various human neoplastic diseases have been extensively studied. However, the clinical use of ATO for solid tumors is limited, and these limitations are because...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026299/ https://www.ncbi.nlm.nih.gov/pubmed/35456577 http://dx.doi.org/10.3390/pharmaceutics14040743 |